146 related articles for article (PubMed ID: 23541130)
1. Plasma exchange for steroid-refractory relapses in multiple sclerosis: an observational, MRI pilot study.
Meca-Lallana JE; Hernández-Clares R; León-Hernández A; Genovés Aleixandre A; Cacho Pérez M; Martín-Fernández JJ
Clin Ther; 2013 Apr; 35(4):474-85. PubMed ID: 23541130
[TBL] [Abstract][Full Text] [Related]
2. Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.
Llufriu S; Castillo J; Blanco Y; Ramió-Torrentà L; Río J; Vallès M; Lozano M; Castellà MD; Calabia J; Horga A; Graus F; Montalban X; Saiz A
Neurology; 2009 Sep; 73(12):949-53. PubMed ID: 19770470
[TBL] [Abstract][Full Text] [Related]
3. The rescue effect of plasma exchange for neuromyelitis optica.
Wang KC; Wang SJ; Lee CL; Chen SY; Tsai CP
J Clin Neurosci; 2011 Jan; 18(1):43-6. PubMed ID: 20888238
[TBL] [Abstract][Full Text] [Related]
4. Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis.
Trebst C; Reising A; Kielstein JT; Hafer C; Stangel M
Blood Purif; 2009; 28(2):108-15. PubMed ID: 19521072
[TBL] [Abstract][Full Text] [Related]
5. Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder.
Bonnan M; Valentino R; Olindo S; Mehdaoui H; Smadja D; Cabre P
Mult Scler; 2009 Apr; 15(4):487-92. PubMed ID: 19324982
[TBL] [Abstract][Full Text] [Related]
6. Immunoadsorption or plasma exchange in steroid-refractory multiple sclerosis and neuromyelitis optica.
Lipphardt M; Mühlhausen J; Kitze B; Heigl F; Mauch E; Helms HJ; Müller GA; Koziolek MJ
J Clin Apher; 2019 Aug; 34(4):381-391. PubMed ID: 30698295
[TBL] [Abstract][Full Text] [Related]
7. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).
Weinstock-Guttman B; Ramanathan M; Lincoff N; Napoli SQ; Sharma J; Feichter J; Bakshi R
Arch Neurol; 2006 Jul; 63(7):957-63. PubMed ID: 16831964
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of acute partial transverse myelitis.
Bourre B; Zéphir H; Ongagna JC; Cordonnier C; Collongues N; Debette S; Fleury MC; Outteryck O; Hannequin D; Vermersch P; de Seze J
Arch Neurol; 2012 Mar; 69(3):357-62. PubMed ID: 22410443
[TBL] [Abstract][Full Text] [Related]
9. [Plasma exchanges in severe and acute inflammatory demyelinating attacks of the central nervous system].
Brunot S; Vukusic S; Fromont A; Couvreur G; Mousson C; Giroud M; Confavreux C; Moreau T
Presse Med; 2011 May; 40(5):e271-8. PubMed ID: 21353760
[TBL] [Abstract][Full Text] [Related]
10. Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.
Ehler J; Koball S; Sauer M; Mitzner S; Hickstein H; Benecke R; Zettl UK
PLoS One; 2015; 10(8):e0134583. PubMed ID: 26244762
[TBL] [Abstract][Full Text] [Related]
11. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
Hurwitz BJ; Jeffery D; Arnason B; Bigley K; Coyle P; Goodin D; Kaba S; Kirzinger S; Lynch S; Mandler R; Mikol D; Rammohan K; Sater R; Sriram S; Thrower B; Boateng F; Jakobs P; Wash MB; Bogumil T
Clin Ther; 2008 Jun; 30(6):1102-12. PubMed ID: 18640466
[TBL] [Abstract][Full Text] [Related]
12. Spinal cord involvement in Balo's concentric sclerosis.
Kreft KL; Mellema SJ; Hintzen RQ
J Neurol Sci; 2009 Apr; 279(1-2):114-7. PubMed ID: 19181346
[TBL] [Abstract][Full Text] [Related]
13. [Plasmapheresis: its use in multiple sclerosis and other demyelinating processes of the central nervous system. An observation study].
Meca-Lallana JE; Rodríguez-Hilario H; Martínez-Vidal S; Saura-Luján I; Carretón-Ballester A; Escribano-Soriano JB; Martín-Fernández J; Genovés-Aleixandre A; Mateo-Bosch E; Fernández-Barreiro A
Rev Neurol; 2003 Nov 16-30; 37(10):917-26. PubMed ID: 14634919
[TBL] [Abstract][Full Text] [Related]
14. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability.
Mikaeloff Y; Suissa S; Vallée L; Lubetzki C; Ponsot G; Confavreux C; Tardieu M;
J Pediatr; 2004 Feb; 144(2):246-52. PubMed ID: 14760270
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditions.
Pohl D
Curr Opin Neurol; 2008 Jun; 21(3):366-72. PubMed ID: 18451724
[TBL] [Abstract][Full Text] [Related]
16. Outcomes after early administration of plasma exchange in pediatric central nervous system inflammatory demyelination.
Bigi S; Banwell B; Yeh EA
J Child Neurol; 2015 Jun; 30(7):874-80. PubMed ID: 25246301
[TBL] [Abstract][Full Text] [Related]
17. Predictors of outcome in a large retrospective cohort of patients with transverse myelitis.
Gastaldi M; Marchioni E; Banfi P; Mariani V; Di Lodovico L; Bergamaschi R; Alfonsi E; Borrelli P; Ferraro OE; Zardini E; Pichiecchio A; Cortese A; Waters P; Woodhall M; Ceroni M; Mauri M; Franciotta D
Mult Scler; 2018 Nov; 24(13):1743-1752. PubMed ID: 28967297
[TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.
Ghezzi A; Bergamaschi R; Martinelli V; Trojano M; Tola MR; Merelli E; Mancardi L; Gallo P; Filippi M; Zaffaroni M; Comi G;
J Neurol; 2004 Jan; 251(1):47-52. PubMed ID: 14999489
[TBL] [Abstract][Full Text] [Related]
20. Immunoadsorption therapy for steroid-unresponsive relapses in patients with multiple sclerosis.
Trebst C; Bronzlik P; Kielstein JT; Schmidt BM; Stangel M
Blood Purif; 2012; 33(1-3):1-6. PubMed ID: 22086365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
